References
- Krahne D, Heymann A, Spies C. How to monitor delirium in the ICU and why it is important. Clinl Effect Nurs. 2006;9:269–79.
- Urden L, Stacy K, Rajabpour NM, et al. Study of Predictors of Delirium Incidence in Hospitalized Patients In Intensive Care Units. Nurs Midwife Commun. 2014;26(18):25–35.
- Javaherforooshzadeh F, Monajemzadeh SA, Soltanzadeh M, Janatmakan F, Salari A, Saeed H. A Comparative Study of the Amount of Bleeding and Hemodynamic Changes between Dexmedetomidine Infusion and Remifentanil Infusion for Controlled Hypotensive Anesthesia in Lumbar Discopathy Surgery: A Double-Blind, Randomized, Clinical Trial. Anesth Pain Med. 2018;8(2):e66959.
- Al Huraizi AR, Al-Maqbali JS, Al Farsi RS, et al. Delirium and Its Association with Short- and Long-Term Health Outcomes in Medically Admitted Patients: A Prospective Study. J Clin Med. 2023;12(16):5346.
- Nelson S, Muzyk AJ, Bucklin MH, Brudney S, Gagliardi JP. Defining the Role of Dexmedetomidine in the Prevention of Delirium in the Intensive Care Unit. BioMed Res Int. 2015;2015:635737.
- Daou M, Telias I, Younes M, Brochard L, Wilcox ME. Abnormal Sleep, Circadian Rhythm Disruption, and Delirium in the ICU: Are They Related?. Front Neurol. 2020;11:549908.
- Jeong IS, Cho MK. Factors Affecting Delirium in ICU Patients. Int J Environ Res Public Health. 2023;20(10):5889.
- Tran A, Blinder H, Hutton B et al. Alpha-2 agonists for sedation in mechanically ventilated neurocritical care patients: a systematic review protocol. Syst Rev. 2016:5(1):154
- Pedersen SS, Kirkegaard T, Jørgensen MB, Jørgensen VL. Effects of a screening and treatment protocol with haloperidol on post-cardiotomy delirium: a prospective cohort study. Interact Cardiovasc Thorac Surg. 2014;18(4):438–445.
- Pisani MA, Araujo KL, Murphy TE. Association of cumulative dose of haloperidol with next-day delirium in older medical ICU patients. Crit. Care Med. 2015;43(5):996–1002.
- van den Boogaard M, Schoonhoven L, van Achterberg T, van der Hoeven JG, Pickkers P. Haloperidol prophylaxis in critically ill patients with a high risk for delirium. Critical care. 2013;17(1):R9.
- Page VJ, Ely EW, Gates S, et al. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir. Med. 2013;1(7):515–523.
- Leuch S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. The Lancet. 2013;382(9896):951–962.
- Tamang K, Kc B, Kuikel S, Thapa S. Haloperidol-induced sudden cardiac arrest in a recently detected HIV and hepatitis C patient: A unique case report. SAGE Open Med Case Rep. 2023;11:2050313X231220792.
- Collet MO, Caballero J, Sonneville R, et al. Prevalence and risk factors related to haloperidol use for delirium in adult intensive care patients: the multinational AID-ICU inception cohort study. Intensive Care Med 2018; 44(7): 1081–1089.
- Dotson B. Comparing Dexmedetomidine With Haloperidol for the Treatment of Hyperactive Delirium in Nonintubated ICU Patients. Crit Care Med. 2016;44(12):1259–60.
- Keating GM. Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting. Drugs. 2015;75(10):1119–30.
- Reade MC, Eastwood GM, Bellomo R, et al. Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated Delirium: A Randomized Clinical Trial. JAMA. 2016;315(14):1460–8.
- Jalonen J, Hynynen M, Kuitunen A, et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology. 1997;86:331–345.
- Kim Y, Kim SY, Lee JS, Kong HJ, Han DW. Effect of dexmedetomidine on the corrected QT and Tp-e intervals during spinal anesthesia. Yonsei Med J. 2014;55(2):517–522.
- Raschi E, Poluzzi E, Godman B, et al. Torsadogenic Risk of Antipsychotics: Combining Adverse Event Reports with Drug Utilization Data across Europe. PLoS ONE 2013;8(11):81208.
- Metzger E, Friedman R. Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill. Journal of Clin. Psychopharmacol. 1993;13(2):128–132.
- Perrault LP, Denault AY, Carrier M, Cartier R, Bélisle S. Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery. Can J Anaesth. 2000;47(3):251–254.
- O’Brien JM, Rockwood RP, Suh KI. Haloperidol-induced torsade de pointes. Ann Pharmacother. 1999;33(10):1046–1050.
- Li M, Ramos LG. Drug-Induced QT Prolongation And Torsades de Pointes. P T. 2017;42(7):473–477.
- Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2010;55(9):934–947.
- Burns KM, Greene EA. Long QT syndrome unmasked by dexmedetomidine: a case report. Congenital heart disease. 2014;9(1):E11–E15.
- Görges M, Whyte SD, Sanatani S, Dawes J, Montgomery CJ, Ansermino JM. Changes in QTc associated with a rapid bolus dose of dexmedetomidine in patients receiving TIVA: a retrospective study. Paediatric anaesthesia. 2015;25(12):1287–1293.
- Fujii E, Fujino K, Fujii M, Furuno M, Sugimoto Y, Takabuchi S, et al. Dexmedetomidine attenuates the positive chronotropic effects of intravenous atropine in patients with bradycardia during spinal anaesthesia: a retrospective study. JA Clinical Reports. 2018;4(1):1–6.
- Grmec S, Mally S, Klemen P. Glasgow Coma Scale score and QTc interval in the prognosis of organophosphate poisoning. Acad Emerg Med. 2004;11(9):925–930.
- George TK, Chase D, Peter JV, et al. Association between a prolonged corrected QT interval and outcomes in patients in a medical Intensive Care Unit. Indian J Crit Care Med. 2015;19(6):326–332)
- Ye M, Zhang J, Liu J, Zhang M, Yao F, & Cheng Y. Association Between Dynamic Change of QT Interval and Long-Term Cardiovascular Outcomes: A Prospective Cohort Study. Front Cardiovasc Med. 2021;8:756213.
- Rabkin SW, Cheng BJ, Thompson DJ. Detailed analysis of the impact of age on the QT interval. J Geriatr Cardiol. 2016;13(9):740–748.